Download details
Neurocrine Biosciences announces positive data from NBI 98854 Phase III trial in tardive dyskinesia
Information
Created
Thursday, 23 February 2023 14:39
Changed
Thursday, 23 February 2023 14:39
Version
2023
Size
562.74 KB
Rating
Created by
Jim Davis
Downloads
102